Clinical Significance of Urinary Liver-Type Fatty Acid Binding Protein in Type 2 Diabetic Nephropathy

Clinical Significance of Urinary Liver-Type Fatty Acid Binding Protein in Type 2 Diabetic Nephropathy - Urinary L-FABP and Diabetic Nephropathy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000002483

Enrollment

150

Registered

2009-09-12

Start date

2004-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetic Nephropathy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 2 diabetes in the outpatient clinics at the Department of Internal Medicine, St Marianna University School of Medicine Hospital

Exclusion criteria

Exclusion criteria: no history of liver disease, primary kidney disease, cancer, or collagen disease; the degree of hematuria not more severe than the degree of proteinuria; and no hemodialysis

Design outcomes

Primary

Measure	Time frame
progression to higher stage of diabetic nephropathy.	—

Countries

Japan

Contacts

Public ContactKamijo-Ikemori Atsuko

KZ-001 Nephrology and Hypertension, Internal Medicine

a2kamijo@marianna-u.ac.jp81-44-977-8111

Outcome results